RBBP4 and pancreatic neoplasm: Mechanistic analyses revealed that miR-6794-3p inhibits RBBP4 by directly binding to the 3′-UTR of RBBP4 and thereby upregulating GRGL2 to suppress pancreatic cancer cell invasion, migration, and metastasis.